Edition:
United States

Pearson PLC (PSON.L)

PSON.L on London Stock Exchange

964.50GBp
12:01pm EDT
Change (% chg)

-9.50p (-0.98%)
Prev Close
974.00p
Open
975.00p
Day's High
976.00p
Day's Low
963.00p
Volume
2,665,108
Avg. Vol
2,947,613
52-wk High
1,227.60p
52-wk Low
644.50p

Select another date:

Thu, Jul 14 2016

BRIEF-Former Valeant CEO Pearson sold nearly 5 mln shares, options for $96.8 mln -CNBC

* Former Valeant CEO Pearson sold nearly 5 million Valeant shares and options for $96.8 million - CNBC Source text: (http://cnb.cx/29XOtj4) Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Pearson sees possible Brazil targets as education deals heat up

SAO PAULO, June 8 Pearson Plc is looking at several possible acquisitions in Brazil amid a wave of merger talks, an executive told Reuters, as the British education company aims to take advantage of a favorable exchange rate in a market where it is fast expanding.

BRIEF-Valeant's former CEO may remain as consultant through 2017

* Under separation agreement with former CEO pearson, he will provide consulting services to company through december 31, 2017

U.S. contract losses hit education firm Pearson's first quarter

LONDON Pearson , the British education company struggling to cope with a downturn in its biggest markets, reported a further fall in sales on Friday as the loss of high-profile testing contracts in the United States hit first-quarter results.

BRIEF-Valeant says 3 new independent directors nominated to board

April 29 Valeant Pharmaceuticals International Inc :

Valeant CEO to tell U.S. Senate he regrets raising heart drug prices

WASHINGTON, April 27 Outgoing Valeant Pharmaceuticals Chief Executive Michael Pearson plans to tell a U.S. Senate panel on Wednesday that he regrets his decision to acquire and jack up the price of two life-saving heart drugs, saying it was all a "mistake."

UPDATE 1-Valeant CEO agrees to be deposed by Senate committee

April 13 Valeant Pharmaceuticals International Inc's outgoing chief executive, Michael Pearson, consented to be deposed by a U.S. Senate committee later this month, after the panel threatened to hold him in contempt for failing to comply with a subpoena.

BRIEF-U.S. Senate Special Committee on Aging to depose Valeant CEO Pearson

* U.S. Senate Special Committee on Aging says Senate Special Committee on Aging to depose Michael Pearson

Pearson sticks to Penguin position after partner's comments

LONDON Pearson said there was no change in its position regarding its stake in its Penguin Random House joint venture after partner Bertelsmann said earlier on Tuesday it wanted to increase its holding.

Select another date: